News Conference News ACC 2012 ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released Yael L. Maxwell April 02, 2012
News Conference News ACC 2012 PARTNER: TAVR Remains as Effective as Surgery at 2 Years March 26, 2012
News Conference News ACC 2012 ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months March 24, 2012
News Conference News Study Looks at Surgery vs. Transcatheter Treatment for Aortic Stenosis Plus CAD November 15, 2011
News Conference News STACCATO: Transapical TAVR Inferior to Surgery for Operable Elderly Patients November 09, 2011
News Conference News PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years November 09, 2011
News Conference News Complications After TAVR: Manageable, But Important to Consider November 09, 2011
News Conference News Mitral, Aortic Regurgitation Increase Mortality After Transcatheter Valve Replacement November 08, 2011
News Conference News ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details Caitlin E. Cox April 08, 2011
News Conference News Study Focuses on Permanent Pacemaker Predictors in TAVI vs. Surgery Jason Kahn April 05, 2011
News Conference News PARTNER: TAVI Cost Effective Compared With Standard Care Jason Kahn April 03, 2011
News Conference News PARTNER: In High-Risk Surgical Candidates, TAVI Proves Just as Effective Caitlin E. Cox April 03, 2011